Framework Based Analysis of Corporate Leadership, Emotional Intelligence (EI) Competencies and Organizational Performance – A Developmental Perspective

The study focuses on the issues of organizational performance, particularly related to developing corporate leadership to the level of effectiveness and the extended result as an outcome on organizational performance. We propose a model by plausibly linking the competencies related to emotional intelligence with effectiveness of corporate leadership, eventually fashioning out a high performance organization. In order to develop a framework, it includes conceptions grounded on EI as exogenous variable (ξ), Effective corporate leadership (ECL) as endogenous (η) variable and high performance organisation as outcome variable. The feedback composed was collected from 1171 corporate leaders serving in large business organizations across Pakistan. For analysis purpose, after data cleansing, SEM is employed to obtain results related to model fit and testing of hypotheses. Measurement and Structural Models approve the propositions of the study. After analysis, it is pertinent to mention that findings show great role of the competencies of EI with corporate leadership, and as a trickled down effect on overall organizational performance. The results also show how leadership can be developed to the level of effectiveness and thus can lead to achieve corporate reputation, employee commitment, market performance and financial performance of an organization. It is seen that the influence of EI competencies has not only the impact on the effectiveness of corporate leadership but also on overall organisational performance. &nbsp

Methyl 2-(1,1,3-trioxo-2,3-dihydro-1,2-benzothia­zol-2-yl)acetate: a monoclinic polymorph

In the title compound, C10H9NO5S, the fused ring system and the planar (r.m.s. deviation = 0.0037 Å) methoxy­carbonyl­methyl side chain form a dihedral angle of 84.67 (10)°. The crystal structure is stabilized by inter­molecular C—H⋯O hydrogen bonds. A triclinic polymorph of the title compound is already known [Siddiqui et al. (2008 ▶). Acta Cryst. E64, o859]

N-(4-Chloro-2-nitro­phen­yl)-N-(methyl­sulfon­yl)acetamide

The title compound, C9H9ClN2O5S, is of inter­est as a precursor to biologically active substituted quinolines and related compounds. The structure displays inter­molecular C—H⋯O inter­actions. Each mol­ecule is linked to two adjacent neighbours via weak centrosymmetric dimer-forming inter­actions, forming chains in the [101] direction

2-(Prop-2-en­yl)-1,2-benzisothia­zol-3(2H)-one 1,1-dioxide

In the title compound, C10H9NO3S, the benzisothia­zole group is almost planar (with a maximum deviation of 1.61 Å). The crystal structure is stabilized by weak inter­molecular C—H⋯O hydrogen bonds, forming a chain of mol­ecules along b

Methyl 2-(benzene­sulfonamido)acetate

The title compound, C9H11NO4S, is of inter­est as a precursor to biologically active benzothia­zines. The crystal structure is stabilized by inter­molecular N—H⋯O and C—H⋯O inter­actions

N-(3,4-Dimethyl­phen­yl)-4-hydr­oxy-2-methyl-2H-1,2-benzothia­zine-3-carboxamide 1,1-dioxide

1,2-Benzothia­zines similar to the title compound, C18H18N2O4S, are well known in the literature for their biological activities and are used as medicines in the treatment of inflammation and rheumatoid arthritis. The thia­zine ring adopts a distorted half-chair conformation. The enolic H atom is involved in an intra­molecular O—H⋯O hydrogen bond, forming a six-membered ring. In the crystal, mol­ecules arrange themselves into centrosymmetric dimers by means of pairs of weak inter­molecular N—H⋯O hydrogen bonds

1-(4-Hydr­oxy-2-methyl-1,1-dioxo-2H-1,2-benzothia­zin-3-yl)ethanone

In the title compound, C11H11NO4S, the thia­zine ring adopts a distorted half-chair conformation. The enolic H atom is involved in an intra­molecular O—H⋯O hydrogen bond, forming a six-membered ring. Mol­ecules are linked through weak inter­molecular C—H⋯O hydrogen bonds, resulting in chains lying along the b axis

2-[(E)-3-Phenyl­prop-2-en­yl]-1,2-benzisothia­zol-3(2H)-one 1,1-dioxide

In the crystal structure of the title compound, C16H13NO3S, the benzisothia­zole group is almost planar (r.m.s. deviation for all non-H atoms excluding the two O atoms bonded to S = 0.009 Å). The dihedral angle between the fused ring and the terminal ring is 13.8 (1)°. In the crystal, mol­ecules are linked through inter­molecular C—H⋯O contacts forming a chain of mol­ecules along b

Methyl 2-allyl-4-hydr­oxy-2H-1,2-benzothia­zine-3-carboxyl­ate 1,1-dioxide

In the title compound, C13H13NO5S, the thia­zine ring adopts a distorted half-chair conformation. Intra­molecular O—H⋯O and C—H⋯O hydrogen bonds give rise to two six-membered hydrogen bonded rings. In the crystal, mol­ecules are linked through weak inter­molecular C—H⋯O hydrogen bonds, resulting in a zigzag chain lying along the c axis